Flexion Therapeutics
FLXN
#7784
Rank
C$0.63 B
Marketcap
C$12.65
Share price
0.00%
Change (1 day)
8,263.63%
Change (1 year)

Earnings for Flexion Therapeutics (FLXN)

Earnings in 2021 (TTM): -C$0.11 Billion

According to Flexion Therapeutics 's latest financial reports the company's current earnings are C$0.10 Billion. In 2020 the company made an earning of -C$0.13 Billion, an increase over its 2019 earnings that were of -C$0.19 Billion.

Earnings history for Flexion Therapeutics from 2013 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-C$0.11 Billion-22.62%
2020-C$0.13 Billion-29.78%
2019-C$0.19 Billion-13.8%
2018-C$0.22 Billion21.98%
2017-C$0.18 Billion79.92%
2016-C$97.3 Million53.34%
2015-C$63.45 Million69.98%
2014-C$37.33 Million51.72%
2013-C$24.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.03 B-32,824.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$14.69 B-13,440.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
C$5.22 M-104.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
C$18.26 M-116.58%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-C$14.27 Million-87.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Ampio Pharmaceuticals
AMPE
-C$11.98 Million-89.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-C$87.1 Million-20.90%๐Ÿ‡บ๐Ÿ‡ธ USA